ZNF146 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.265600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.492600E-01
Normal-vs-Stage2
9.849200E-01
Normal-vs-Stage3
1.770230E-01
Normal-vs-Stage4
3.269600E-01
Stage1-vs-Stage2
2.305200E-01
Stage1-vs-Stage3
1.925440E-01
Stage1-vs-Stage4
1.862430E-01
Stage2-vs-Stage3
1.951220E-01
Stage2-vs-Stage4
1.095360E-01
Stage3-vs-Stage4
6.716200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.279600E-01
Normal-vs-AfricanAmerican
9.507400E-01
Normal-vs-Asian
7.247200E-01
Caucasian-vs-AfricanAmerican
8.276200E-01
Caucasian-vs-Asian
5.700600E-01
AfricanAmerican-vs-Asian
6.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.167800E-01
Normal-vs-Female
9.569400E-01
Male-vs-Female
8.294800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.986600E-01
Normal-vs-Age(41-60Yrs)
6.941800E-01
Normal-vs-Age(61-80Yrs)
7.987200E-01
Normal-vs-Age(81-100Yrs)
3.962200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.324000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.709200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.035200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.569700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.225500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.446400E-01
Normal-vs-Daily Drinker
6.654000E-01
Normal-vs-Weekly Drinker
5.962000E-01
Normal-vs-Occasional Drinker
6.075200E-01
Normal-vs-Social Drinker
9.819000E-01
Non Drinker-vs-Daily Drinker
7.626400E-01
Non Drinker-vs-Weekly Drinker
8.705000E-01
Non Drinker-vs-Occasional Drinker
2.774100E-02
Non Drinker-vs-Social Drinker
3.006200E-01
Daily Drinker-vs-Weekly Drinker
9.191600E-01
Daily Drinker-vs-Occasional Drinker
7.640300E-02
Daily Drinker-vs-Social Drinker
4.694400E-01
Weekly Drinker-vs-Occasional Drinker
9.042100E-02
Weekly Drinker-vs-Social Drinker
4.655800E-01
Occasional Drinker-vs-Social Drinker
4.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.509600E-01
Normal-vs-Grade 2
4.641600E-02
Normal-vs-Grade 3
8.049700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.543700E-02
Grade 1-vs-Grade 3
2.057600E-02
Grade 1-vs-Grade 4
2.509600E-01
Grade 2-vs-Grade 3
1.494590E-01
Grade 2-vs-Grade 4
4.641600E-02
Grade 3-vs-Grade 4
8.049700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.358000E-01
Normal-vs-NonDiabetic
8.435000E-01
Diabetic-vs-NonDiabetic
8.646000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.805000E-01
Normal-vs-NoPancreatitis
8.982200E-01
Pancreatitis-vs-NoPancreatitis
5.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.179800E-01
Normal-vs-N1
9.990400E-01
N0-vs-N1
4.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.372400E-01
Normal-vs-TP53-NonMutant
7.687400E-01
TP53-Mutant-vs-TP53-NonMutant
2.592000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
